Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor
Saved in:
| Published in | Frontiers in Pharmacology Vol. 10 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | Japanese |
| Published |
Frontiers Media SA
18.02.2019
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1663-9812 |
| DOI | 10.3389/fphar.2019.00076 |
Cover
| Author | Sheng-Nan Wu Te-Ling Lu Wei-Ting Chang Chee-Hong Chan |
|---|---|
| Author_xml | – sequence: 1 fullname: Te-Ling Lu – sequence: 2 fullname: Wei-Ting Chang – sequence: 3 fullname: Chee-Hong Chan – sequence: 4 orcidid: 0000-0002-5208-3253 fullname: Sheng-Nan Wu |
| BackLink | https://cir.nii.ac.jp/crid/1870865118225730304$$DView record in CiNii |
| BookMark | eNotjEtLAzEYRYMoWGv3LrNwp1PzmMkky1JaLVYFKd1KHl9sypAMk7Tov7eim3PhcDlX6DymCAjdUDLlXKoH3-_0MGWEqikhpBVnaESF4JWSlF2iSc77kyZcKS7qEfpaHIODaAH7NOCF92BLOAJ-OXQl9B3g57tqfhgGiAWv4i6YUEKKGZtvvEndUfdFx3us8WuKVQ99OcXwLBb9mWLIBSePtzqnfoCcQ8Rbht_Bnm5puEYXXncZJv87RpvlYjN_qtZvj6v5bF3tVVNXloEBAa0xLXAFtIHWGW5Uo6QTznrrjKPWC3BU-IbUBLyVQJnkmtCGcD5Gt3_ZGMKHDb-ksiVSNJRKxpqWE05q_gPxH1-g |
| ContentType | Journal Article |
| DBID | RYH |
| DOI | 10.3389/fphar.2019.00076 |
| DatabaseName | CiNii Complete |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1663-9812 |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM RYH |
| ID | FETCH-LOGICAL-j954-c2ebe6e7bb7e39e15e7db3b9598d6dcfcdbd1cf6ed16f5040efc8e1283a015033 |
| IEDL.DBID | M48 |
| IngestDate | Thu Jun 26 22:36:18 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | Japanese |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-j954-c2ebe6e7bb7e39e15e7db3b9598d6dcfcdbd1cf6ed16f5040efc8e1283a015033 |
| ORCID | 0000-0002-5208-3253 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2019.00076 |
| ParticipantIDs | nii_cinii_1870865118225730304 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-02-18 |
| PublicationDateYYYYMMDD | 2019-02-18 |
| PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-18 day: 18 |
| PublicationDecade | 2010 |
| PublicationTitle | Frontiers in Pharmacology |
| PublicationYear | 2019 |
| Publisher | Frontiers Media SA |
| Publisher_xml | – name: Frontiers Media SA |
| SSID | ssj0000399364 |
| Score | 2.0584557 |
| SourceID | nii |
| SourceType | Publisher |
| SubjectTerms | delayed-rectifier K+ current erg-mediated K+ current M-type K+ current membrane potential Pharmacology pituitary cell RM1-950 Therapeutics. Pharmacology tolvaptan |
| Title | Evidence for Effective Multiple K+-Current Inhibitions by Tolvaptan, a Non-peptide Antagonist of Vasopressin V2 Receptor |
| URI | https://cir.nii.ac.jp/crid/1870865118225730304 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1NT8JAEN0ono2fUSNkDoaLVC3tbtuDMcRIUAPhUAg3s5-hhrQIaOi_d7YtwQOJl17avexk5s3rzLwh5Ib5gTAhV47kLhIUKR8cgcDmKNHWCj0kMsxOI_cHrDfy3yZ0sh2Pri5wuZPa2X1So8Xsbv2VP6HDP1rGiXh7b-ZTbqU9XSs9ibx8nxwgLjFLxfpVsl_EZYvFzC9rlTsPIr6kSfIHX7pH5LBKDKFTWvKY7H3yE9IclsrSeQvi7aDUsgVNGG41p_NTst5sBwVMQqGUJMY4Bv2qXxDebzdSTPCaThNRdmqByCHOZj98jjliCzgMstSZ20YXpaGT2oqVVdaFzMCYL8uFKUkK4zZguomfZYszEndf4ueeUy1VcD4j6juyjVZjOhAi0F6kXaoDJTwR0ShUTEkjlVCuNEwrlxmKHq6NDDWCmMftvxHPOye1NEv1BQGhApd7Ukch5b7na6GEoUwF0pUBFWF0Sep4mx8ysU8X40LICjqDQcKzBdmrf95fk9pq8a3rCPor0SjIcqOw6C9EDK60 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+for+Effective+Multiple+K%2B-Current+Inhibitions+by+Tolvaptan%2C+a+Non-peptide+Antagonist+of+Vasopressin+V2+Receptor&rft.jtitle=Frontiers+in+Pharmacology&rft.au=Te-Ling+Lu&rft.au=Wei-Ting+Chang&rft.au=Chee-Hong+Chan&rft.au=Sheng-Nan+Wu&rft.date=2019-02-18&rft.pub=Frontiers+Media+SA&rft.eissn=1663-9812&rft.volume=10&rft_id=info:doi/10.3389%2Ffphar.2019.00076 |